Search results
Antimicrobial peptide from cows shows potential for treating hypervirulent bacteria
Phys.org· 2 days agoIn a study published in Cell Reports Physical Science, Fleeman showed that an antimicrobial peptide...
Unraveling the roles of non-coding DNA explains childhood cancer's resistance to chemotherapy
Medical Xpress· 3 days agoThe findings are published in Nature Communications. Acute lymphoblastic leukemia (ALL) is the most common childhood cancer. The researchers studied resistance variants found in the non-coding ...
Altamira Therapeutics files new RNA delivery patent By Investing.com
Investing.com· 3 days agoAltamira Therapeutics Ltd. (NASDAQ:CYTO), a biopharmaceutical company focusing on RNA delivery...
Deciphera Pharmaceuticals (NASDAQ:DCPH) Downgraded by Leerink Partnrs to Market Perform
ETF DAILY NEWS· 2 days agoLeerink Partnrs downgraded shares of Deciphera Pharmaceuticals (NASDAQ:DCPH – Free Report) from an outperform rating to a market perform rating in a research note published on Monday, Zacks.com ...
HC Wainwright Reaffirms “Buy” Rating for Purple Biotech (NASDAQ:PPBT)
ETF DAILY NEWS· 6 days agoHC Wainwright reaffirmed their buy rating on shares of Purple Biotech (NASDAQ:PPBT – Free Report) in a report issued on Friday, Benzinga reports. HC Wainwright currently has a $10.00 price target ...
Deciphera Pharmaceuticals’ (DCPH) Market Perform Rating Reaffirmed at JMP Securities
ETF DAILY NEWS· 4 days agoJMP Securities reaffirmed their market perform rating on shares of Deciphera Pharmaceuticals (NASDAQ:DCPH – Free Report) in a research note released on Tuesday morning, Benzinga reports. Several ...
Deciphera Pharmaceuticals (NASDAQ:DCPH) Rating Reiterated by Jonestrading
ETF DAILY NEWS· 4 days agoDeciphera Pharmaceuticals (NASDAQ:DCPH – Get Free Report)‘s stock had its “hold” rating restated by investment analysts at Jonestrading in a research note issued to investors on Monday, Benzinga ...
Jefferies Financial Group Reiterates Hold Rating for Deciphera Pharmaceuticals (NASDAQ:DCPH)
ETF DAILY NEWS· 4 days agoDeciphera Pharmaceuticals (NASDAQ:DCPH – Get Free Report)‘s stock had its “hold” rating reissued by investment analysts at Jefferies Financial Group in a report released on Monday, Benzinga ...
TAXIS Pharmaceuticals Announces $2.67 Million NIH Grant to Advance Research and Development of...
PRWeb· 3 days ago"The NIH grant is further validation of our science and of the value our EPIs can deliver to communities around the world." TAXIS Pharmaceuticals' investigational EPIs represent a new anti-resistance ...
Deciphera Pharmaceuticals (NASDAQ:DCPH) Given “Neutral” Rating at Guggenheim
ETF DAILY NEWS· 2 days agoDeciphera Pharmaceuticals (NASDAQ:DCPH – Get Free Report)‘s stock had its “neutral” rating reissued by analysts at Guggenheim in a research note issued on Tuesday, Benzinga reports. Several ...